Sector : Pharmaceuticals and health care | Smallcap | BSE
Date Time | Announcment |
|---|---|
| May 28, 2026, 5:52 AM IST | Medicamen Biotec - Corporate Action-Board to consider Dividend |
| May 28, 2026, 5:44 AM IST | Medicamen Biotec - Compliances - Regulation 32 (1) And (3) - Statament Of Deviation & Variation Report - March 2026 |
| May 27, 2026, 8:56 PM IST | Medicamen Biotec - Audited Stabdalone & Consolidated Financial Results For The Quarter And Year Ended On March 31, 2026 |
| May 20, 2026, 9:29 PM IST | Medicamen Biotec - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated ) For The |
| Apr 16, 2026, 10:06 PM IST | Medicamen Biotec - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 06, 2026, 9:51 PM IST | Medicamen Biotec - Announcement Under Regulation 30 (LODR) - Intimation Regarding Incorrect Event Disply On NSDL Portal |
| Feb 21, 2026, 10:18 PM IST | Medicamen Biotec - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015 |
| Feb 18, 2026, 11:31 PM IST | Medicamen Biotec - Announcement under Regulation 30 (LODR)-Change in Management |
| Feb 13, 2026, 9:55 PM IST | Medicamen Biotec - Announcement under Regulation 30 (LODR)-Change in Management |
| Feb 13, 2026, 9:30 PM IST | Medicamen Biotec - Unaudited Financial Results For The Quarter Ended On December 31, 2025 |
1 of 10 pages
✕